Anjali Chudasama

Anjali Chudasama has over 20 years of experience in the field of clinical trials and research. Anjali currently works as a Senior Manager, Clinical Trials at Bavarian Nordic, where they focus on managing large Phase III Clinical Trials for Vector-Based Vaccines, specifically Chikungunya Virus VLP Vaccine. Their responsibilities include independently managing complex clinical trial delivery, following standard operating procedures and regulatory guidelines, and finding innovative ways to conduct clinical trials that are less burdensome on sites and patients.

Prior to their role at Bavarian Nordic, Anjali worked as a Senior Manager, Clinical Trials at Emergent BioSolutions. Their main focus areas were Vector Vaccine for Lassa Fever and Chikungunya Virus VLP Vaccine. In this role, they also independently managed complex clinical trial delivery, followed standard operating procedures and regulatory guidelines, and contributed to the development of systems for regulatory compliance and enhanced efficiency.

Before their tenure at Emergent BioSolutions, Anjali held various positions in the clinical research field. Anjali served as the President of Ishta Clinical Research, Inc., where they provided clinical research monitoring and project management services across multiple therapeutic areas. Anjali also held positions at Jubilant Clinsys Inc., Cetero Research, Medicure Inc., Cangene Corporation, The Cooper Institute, and OZ Systems, where they gained experience in business development, contract research organization services, and clinical research monitoring.

Anjali holds a strong track record of effectively managing clinical trials, ensuring timely completion of activities and deliverables, and working in a dynamic and complex environment. Their expertise spans a wide range of therapeutic areas, including dermatology, oncology, transplantation medicine, infectious diseases, cardiology, nephrology, neurology, and immunology.

Overall, Anjali Chudasama's work experience demonstrates their extensive knowledge and experience in clinical trials and research, as well as their ability to independently manage complex projects and contribute to regulatory compliance and efficiency improvements.

Anjali Chudasama's education history begins with a Bachelor of Science (B.Sc) degree in Microbiology, obtained from the University of Manitoba from 1993 to 1997. Anjali then pursued a Master of Science (M.Sc) degree in Epidemiology and Biostatistics from the University of Alberta, from 1997 to 1999. Later, in 1999 to 2001, they attended The University of Texas Health Science Center at Houston (UTHealth Houston), where they earned a Master of Public Health (MPH) degree with a focus on Disease Control. In 2004 to 2005, Anjali Chudasama completed a Clinical Research Certificate program in Health Professions and Related Clinical Sciences, Other at Red River College Polytechnic.

In addition to their formal education, Anjali Chudasama has obtained various certifications. These include Certified Clinical Research Associate (CCRA) and Certified Clinical Research Professional (CCRP) from the Association of Clinical Research Professionals, acquired in July and September 2007, respectively. Anjali has also completed several online courses, such as GCP Course: Audits and Inspections of Clinical Trials of Drugs and Biologics and Protocol Registration and Results Summary Disclosure in ClinicalTrials.gov from the CITI Program, obtained in February 2022. Anjali Chudasama has demonstrated continuous professional development through numerous LinkedIn certifications related to goal-setting, leadership, and personal development.